Pharminent

Sanofi’s €250m AI-driven R&D collaboration for metabolic disease

Sanofi and Artificial Intelligence (AI)-driven Exscientia have announced a €250m ($271.9m) drug target research collaboration and licence option agreement.  http://www.outsourcing-pharma.com/Preclinical-Research/Sanofi-s-250m-AI-driven-R-D-collaboration-for-metabolic-disease

Filed under: R&D